List view / Grid view
9 April 2015 | By Victoria White
Novogen has announced that studies conducted at UQDI revealed that experimental drug Anisina killed melanoma cells irrespective of their mutational status...
9 April 2015 | By Victoria White
Pfizer has launched a new competitive grants programme to support research projects investigating the role of PCSK9 in health and cardiovascular disease...
9 April 2015 | By Victoria White
Cellectis has established a new subsidiary, Cellectis, Inc. in New York City. The U.S. headquarters includes large state-of-the-art research laboratories...
8 April 2015 | By Victoria White
Inovio has been selected to receive a grant from DARPA to lead a collaborative team to develop multiple treatment and prevention approaches against Ebola...
8 April 2015 | By SMi Group
SMi Group are thrilled to present the 3rd annual European event: Lyophilisation Europe, taking place on 29th & 30th June 2015, in Central London...
8 April 2015 | By Victoria White
Cardio3 has received a Notice of Allowance from the USPTO for a patent application covering TCR-deficient T-Cells which are engineered to express a CAR...
8 April 2015 | By Victoria White
Arvinas to collaborate with MSD to use PROTAC technology to degrade target proteins, with the goal of creating novel therapeutics...
7 April 2015 | By Victoria White
Nabriva, a biotechnology company focused on developing pleuromutilins, has announced the successful completion of a $120 million Series B financing...
7 April 2015 | By Victoria White
Edaravone, a drug used to treat stroke victims, could help stop the progression of Alzheimer’s Disease according to new research...
7 April 2015 | By Victoria White
Pfizer announces that Kathrin Jansen has been appointed Senior Vice President, Vaccine Research & Development, and will report directly to Mikael Dolsten...
7 April 2015 | By Victoria White
PhoreMost, a biopharmaceutical company focused on increasing diversity of novel therapeutics, has been founded to identify new druggable targets for cancer...
7 April 2015 | By Victoria White
Bristol-Myers Squibb get exclusive access to uniQure’s gene therapy technology platform for multiple targets in cardiovascular diseases...
2 April 2015 | By Victoria White
PeptiDream Inc. has announced that Novartis has exercised its option to obtain a nonexclusive license to the Peptide Discovery Platform System technology...
2 April 2015 | By Victoria White
Merck Serono and MMV have announced that an agreement has been signed for Merck Serono to obtain the rights to the antimalarial compound DDD107498...
2 April 2015 | By Victoria White
The U.S. FDA has issued final guidance to assist industry in developing opioid drug products with potentially abuse-deterrent properties...
